CompanyNasdaqMelville, NY

BioRestorative Therapies, Inc

BioRestorative Therapies develops adult stem cell therapies for disc/spine disease and metabolic disorders.

SEC EDGAR ClinicalTrials.gov

S-1Nov 4Latest SEC filing

Form DOct 9$1.4M sold

October 2026

BioRestorative Therapies appoints Donald J. Currie to board of directors

Oct 9PeopleBioRestorative Therapies, Inc